Beep Receives Frost & Sullivan's 2025 North American Technology Innovation Leadership Recognition for Excellence in Scalable, Service-Oriented Autonomous Mobility Solutions
Beep is honored for combining innovation, operational efficiency, and customer trust to…
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®
FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose…